Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Anatomic Stage IV Breast Cancer AJCC v8|Invasive Breast Lobular Carcinoma|Metastatic Breast Lobular Carcinoma|Prognostic Stage IV Breast Cancer AJCC v8
Interventions: PROCEDURE: Computed Tomography|DRUG: Fluciclovine F18|DRUG: Gallium Ga 68 Gozetotide|PROCEDURE: Positron Emission Tomography
Sponsor: Emory University
Collaborators: National Cancer Institute (NCI)|National Institutes of Health (NIH)